IONETIX and AlfaRim have announced a strategic collaboration to accelerate the commercial production of the potent radioisotope Actinium-225. This partnership aims to address supply constraints and provide broader access to next-generation cancer therapies.
Company Information
Company
Ionetix Corp
Location
101 The Embarcadero
Lansing, Michigan, United States
About
IONETIX is a US-based cyclotron and technology company founded in 2009. IONETIX offers turnkey diagnostic radiopharmaceutical services domestically, cyclotron equipment and installation services globally, and is actively developing Targeted Alpha Therapy (TAT) isotope production and TAT pharmaceutical manufacturing services.